Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-lactam Monotherapy vs Bi-therapy in Community-acquired Pneumonia
NCT00818610Phase 4Completed
- Sponsor
- Fonds national suisse de la recherche scientifique
- Start
- Jan 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin + clavulanate, cefuroxime, clarithromycin in community acquired pneumonia (CAP), sponsored by Fonds national suisse de la recherche scientifique. Started Jan 2009; status: completed.
02
Drugs
amoxicillin + clavulanatecefuroximeclarithromycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00818610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818610.